Answers are grounded in this paper and cite their sources.
Background and objectives Gallbladder cancer (GBC) is the most common biliary malignancy, with adenocarcinoma (GB-ADK) being predominant. Gallbladder neuroendocrine carcinoma (GB-NEC) is rare, and its prognosis after R0 surgical resection remains unclear. This study compares survival outcomes after curative surgery between GB-ADK and GB-NEC. Methods This retrospective, multicenter national study included patients who underwent R0 resection for GBC in Algeria (2000–2021). Demographic, clinical, pathological, and treatment-related data were analysed. Overall survival (OS) and disease-free survival (DFS) were assessed using Kaplan-Meier and log-rank tests. Results Eleven centres participated and 1,061 patients were included (1,049 GB-ADK, 12 GB-NEC); incidental GBC was more frequent in the GB-ADK group (45.6% vs. 8.3%; p =0.016). CEA elevation was higher in the GB-NEC group (25% vs. 7.2%; p =0.020). GB-NEC exhibited more advanced stages and greater perineural/vascular invasion, though not statistically significant. Adjuvant chemotherapy was more frequently administered in the GB-NEC group (66.7% vs. 29.2%, p=0.008). No significant differences were observed in OS (p = 0.222) or DFS (p = 0.269) between GB-ADK and GB-NEC groups. Conclusion Despite a more aggressive presentation, GB-NEC did not show worse survival than GB-ADK after curative surgery. Larger studies are needed to confirm these results.
No takes yet. Share an insight, caveat, or question.
Tidjane et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: